✦ LIBER ✦

Erratum to: Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer

✍ Scribed by Philip Q. Bao; Ramesh K. Ramanathan; Alyssa Krasinkas; Nathan Bahary; Barry C. Lembersky; David L. Bartlett; Steven J. Hughes; Kenneth K. Lee; A. James Moser; Herbert J. Zeh

Book ID: 111774142
Publisher: Springer
Year: 2011
Tongue: English
Weight: 107 KB
Volume: 18
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-011-1681-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of Gemcitabine and Erloti

Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer

✍ Philip Q. Bao; Ramesh K. Ramanathan; Alyssa Krasinkas; Nathan Bahary; Barry C. L 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 303 KB

Adjuvant gemcitabine and concurrent radi

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study

✍ Blackstock, A W; Mornex, F; Partensky, C; Descos, L; Case, L D; Melin, S A; Levi 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB

Phase II study of erlotinib plus gemcita

Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer

✍ Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Phase 2 Study of Erlotinib Combined With

Phase 2 Study of Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy in Patients With Resectable Pancreatic Cancer

✍ Herman, Joseph M.; Fan, Katherine Y.; Wild, Aaron T.; Hacker-Prietz, Amy; Wood, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 480 KB

A randomized phase II trial of adjuvant

A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer

✍ Hideyuki Yoshitomi; Akira Togawa; Fumio Kimura; Hiroshi Ito; Hiroaki Shimizu; Hi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

6590 A phase II study of erlotinib plus

6590 A phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer

✍ Nakachi, K.; Okusaka, T.O.; Funakoshi, A.F.; Ioka, T.I.; Yamao, K.Y.; Ohkawa, S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB